The 2014 ESC/EACTS Guidelines on Myocardial Revascularization provide a comprehensive overview of the management strategies for patients with coronary artery disease (CAD). The guidelines are developed by a task force comprising experts from various European cardiology and cardiothoracic surgery societies. They aim to assist healthcare professionals in selecting the best management strategies for individual patients, considering the risk-benefit ratio and patient preferences. Key points covered in the guidelines include: - **Risk Stratification**: Various risk models such as EuroSCORE, EuroSCORE II, STS score, SYNTAX score, and NCDR risk score are discussed for short-term and long-term outcomes. - **Decision-Making**: The importance of multidisciplinary decision-making (Heart Team) is emphasized, highlighting the need for collaboration between cardiologists, cardiac surgeons, and other specialists. - **Diagnosis**: Non-invasive tests like exercise testing and cardiac imaging are recommended to confirm CAD, document ischemia, and guide treatment decisions. - **Revascularization Strategies**: The guidelines compare percutaneous coronary intervention (PCI) with bare-metal stents (BMS) and drug-eluting stents (DES) against medical therapy and coronary artery bypass grafting (CABG). They provide recommendations for different patient populations, including those with stable coronary artery disease (SCAD), non-ST-segment elevation acute coronary syndromes (NSTE-ACS), and ST-segment elevation myocardial infarction (STEMI). - **Timely Intervention**: The guidelines recommend timely revascularization within 2 weeks for patients with severe symptoms or high-risk anatomy, and within 6 weeks for stable SCAD patients. - **Ad hoc PCI**: The use of ad hoc PCI, performed during diagnostic coronary angiography, is discussed, with recommendations based on patient information and institutional protocols. The guidelines also address specific populations such as patients with diabetes, chronic kidney disease, and those requiring valve interventions, providing evidence-based recommendations for their management. Additionally, they cover procedural aspects, antithrombotic treatments, and the implementation of guidelines in clinical practice.The 2014 ESC/EACTS Guidelines on Myocardial Revascularization provide a comprehensive overview of the management strategies for patients with coronary artery disease (CAD). The guidelines are developed by a task force comprising experts from various European cardiology and cardiothoracic surgery societies. They aim to assist healthcare professionals in selecting the best management strategies for individual patients, considering the risk-benefit ratio and patient preferences. Key points covered in the guidelines include: - **Risk Stratification**: Various risk models such as EuroSCORE, EuroSCORE II, STS score, SYNTAX score, and NCDR risk score are discussed for short-term and long-term outcomes. - **Decision-Making**: The importance of multidisciplinary decision-making (Heart Team) is emphasized, highlighting the need for collaboration between cardiologists, cardiac surgeons, and other specialists. - **Diagnosis**: Non-invasive tests like exercise testing and cardiac imaging are recommended to confirm CAD, document ischemia, and guide treatment decisions. - **Revascularization Strategies**: The guidelines compare percutaneous coronary intervention (PCI) with bare-metal stents (BMS) and drug-eluting stents (DES) against medical therapy and coronary artery bypass grafting (CABG). They provide recommendations for different patient populations, including those with stable coronary artery disease (SCAD), non-ST-segment elevation acute coronary syndromes (NSTE-ACS), and ST-segment elevation myocardial infarction (STEMI). - **Timely Intervention**: The guidelines recommend timely revascularization within 2 weeks for patients with severe symptoms or high-risk anatomy, and within 6 weeks for stable SCAD patients. - **Ad hoc PCI**: The use of ad hoc PCI, performed during diagnostic coronary angiography, is discussed, with recommendations based on patient information and institutional protocols. The guidelines also address specific populations such as patients with diabetes, chronic kidney disease, and those requiring valve interventions, providing evidence-based recommendations for their management. Additionally, they cover procedural aspects, antithrombotic treatments, and the implementation of guidelines in clinical practice.